Caxton Associates LP Edwards Lifesciences Corp Transaction History

Caxton Associates LP

$2.65 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $1.61 Million - $2.17 Million	23,203 Added 179.91%	36,100 $2.5 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $326,779 - $378,640	-4,014 Reduced 23.74%	12,897 $1.22 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $407,613 - $463,875	-5,489 Reduced 24.5%	16,911 $1.4 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $341,841 - $437,637	5,005 Added 28.77%	22,400 $1.67 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $1.43 Million - $1.87 Million	17,395 New	17,395 $1.44 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $383,357 - $470,970	-3,604 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $63,186 - $75,368	-614 Reduced 14.56%	3,604 $408,000
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $353,637 - $441,877	4,218 New	4,218 $437,000
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $334,362 - $425,496	-4,664 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $313,374 - $407,820	4,664 New	4,664 $372,000
Q2 2020 Aug 14, 2020	SELL	$57.54 - $76.95 $188,098 - $251,549	-3,269 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $48,898 - $75,573	933 Added 39.94%	3,269 $617,000
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $167,491 - $191,762	2,336 New	2,336 $545,000
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $82,131 - $109,845	-1,715 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $83,445 - $102,378	-1,798 Reduced 51.18%	1,715 $263,000
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $10,272 - $12,414	242 Added 7.4%	3,513 $511,000
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $121,648 - $155,208	3,271 New	3,271 $456,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Account